Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
(NASDAQ: CRVS) Delayed: 13.20 -0.73 (5.24%)
Previous Close $13.93    52 Week High $17.77 
Open $13.76    52 Week Low $9.63 
Day High $13.91    P/E N/A 
Day Low $13.15    EPS $0.00 
Volume 325,115